Assessment of the plan for pre-exposition vaccination with Fuenzalida-Palacios anti-rabies vaccine

Detalhes bibliográficos
Autor(a) principal: Preto,Angela Aparecida
Data de Publicação: 2000
Outros Autores: Gomes,Elisa Maines, Fernandes,Maurício José, Hennig,Nei Adolfo, Germano,Pedro Manoel Leal
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Archives of Biology and Technology
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-89132000000300002
Resumo: Studies ere carried out to monitor the titres of anti-rabies antibodies taken from individuals exposed to the risk of infection. Fifty-seven individuals aged between 20 and 40, were vaccinated with a minimum titre of 1.3 IU Fuenzalida-Palacios type anti-rabies vaccine. The vaccination plan consisted of the application of three doses at two day intervals and a booster applied 28 days after the final dose. The accompainment of the antibody titres was achieved by means of the seroneutralization test over a total period of 18 months. Through the monitoring carried out, it was found to be necessary to apply a booster vaccination to part of the group. Some of these individuals were revaccinated with Fuenzalida-Palacios type vaccine with a minimum titre of 1.3 IU. And some with cellular vaccine with a minimum titre of 2.5 IU. All the individuals responded with titres greater than 0.5 IU, maintaining these levels until the end of the observation period, demonstrating a ready anamnestic response to both immunogens.
id TECPAR-1_4a0981de8f81a33248aac4c6d16fd0ad
oai_identifier_str oai:scielo:S1516-89132000000300002
network_acronym_str TECPAR-1
network_name_str Brazilian Archives of Biology and Technology
repository_id_str
spelling Assessment of the plan for pre-exposition vaccination with Fuenzalida-Palacios anti-rabies vaccineImmunizationrabies vaccineantibodiesneutralizationFuenzalida-PalaciosStudies ere carried out to monitor the titres of anti-rabies antibodies taken from individuals exposed to the risk of infection. Fifty-seven individuals aged between 20 and 40, were vaccinated with a minimum titre of 1.3 IU Fuenzalida-Palacios type anti-rabies vaccine. The vaccination plan consisted of the application of three doses at two day intervals and a booster applied 28 days after the final dose. The accompainment of the antibody titres was achieved by means of the seroneutralization test over a total period of 18 months. Through the monitoring carried out, it was found to be necessary to apply a booster vaccination to part of the group. Some of these individuals were revaccinated with Fuenzalida-Palacios type vaccine with a minimum titre of 1.3 IU. And some with cellular vaccine with a minimum titre of 2.5 IU. All the individuals responded with titres greater than 0.5 IU, maintaining these levels until the end of the observation period, demonstrating a ready anamnestic response to both immunogens.Instituto de Tecnologia do Paraná - Tecpar2000-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-89132000000300002Brazilian Archives of Biology and Technology v.43 n.3 2000reponame:Brazilian Archives of Biology and Technologyinstname:Instituto de Tecnologia do Paraná (Tecpar)instacron:TECPAR10.1590/S1516-89132000000300002info:eu-repo/semantics/openAccessPreto,Angela AparecidaGomes,Elisa MainesFernandes,Maurício JoséHennig,Nei AdolfoGermano,Pedro Manoel Lealeng2007-03-12T00:00:00Zoai:scielo:S1516-89132000000300002Revistahttps://www.scielo.br/j/babt/https://old.scielo.br/oai/scielo-oai.phpbabt@tecpar.br||babt@tecpar.br1678-43241516-8913opendoar:2007-03-12T00:00Brazilian Archives of Biology and Technology - Instituto de Tecnologia do Paraná (Tecpar)false
dc.title.none.fl_str_mv Assessment of the plan for pre-exposition vaccination with Fuenzalida-Palacios anti-rabies vaccine
title Assessment of the plan for pre-exposition vaccination with Fuenzalida-Palacios anti-rabies vaccine
spellingShingle Assessment of the plan for pre-exposition vaccination with Fuenzalida-Palacios anti-rabies vaccine
Preto,Angela Aparecida
Immunization
rabies vaccine
antibodies
neutralization
Fuenzalida-Palacios
title_short Assessment of the plan for pre-exposition vaccination with Fuenzalida-Palacios anti-rabies vaccine
title_full Assessment of the plan for pre-exposition vaccination with Fuenzalida-Palacios anti-rabies vaccine
title_fullStr Assessment of the plan for pre-exposition vaccination with Fuenzalida-Palacios anti-rabies vaccine
title_full_unstemmed Assessment of the plan for pre-exposition vaccination with Fuenzalida-Palacios anti-rabies vaccine
title_sort Assessment of the plan for pre-exposition vaccination with Fuenzalida-Palacios anti-rabies vaccine
author Preto,Angela Aparecida
author_facet Preto,Angela Aparecida
Gomes,Elisa Maines
Fernandes,Maurício José
Hennig,Nei Adolfo
Germano,Pedro Manoel Leal
author_role author
author2 Gomes,Elisa Maines
Fernandes,Maurício José
Hennig,Nei Adolfo
Germano,Pedro Manoel Leal
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Preto,Angela Aparecida
Gomes,Elisa Maines
Fernandes,Maurício José
Hennig,Nei Adolfo
Germano,Pedro Manoel Leal
dc.subject.por.fl_str_mv Immunization
rabies vaccine
antibodies
neutralization
Fuenzalida-Palacios
topic Immunization
rabies vaccine
antibodies
neutralization
Fuenzalida-Palacios
description Studies ere carried out to monitor the titres of anti-rabies antibodies taken from individuals exposed to the risk of infection. Fifty-seven individuals aged between 20 and 40, were vaccinated with a minimum titre of 1.3 IU Fuenzalida-Palacios type anti-rabies vaccine. The vaccination plan consisted of the application of three doses at two day intervals and a booster applied 28 days after the final dose. The accompainment of the antibody titres was achieved by means of the seroneutralization test over a total period of 18 months. Through the monitoring carried out, it was found to be necessary to apply a booster vaccination to part of the group. Some of these individuals were revaccinated with Fuenzalida-Palacios type vaccine with a minimum titre of 1.3 IU. And some with cellular vaccine with a minimum titre of 2.5 IU. All the individuals responded with titres greater than 0.5 IU, maintaining these levels until the end of the observation period, demonstrating a ready anamnestic response to both immunogens.
publishDate 2000
dc.date.none.fl_str_mv 2000-01-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-89132000000300002
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1516-89132000000300002
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S1516-89132000000300002
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Instituto de Tecnologia do Paraná - Tecpar
publisher.none.fl_str_mv Instituto de Tecnologia do Paraná - Tecpar
dc.source.none.fl_str_mv Brazilian Archives of Biology and Technology v.43 n.3 2000
reponame:Brazilian Archives of Biology and Technology
instname:Instituto de Tecnologia do Paraná (Tecpar)
instacron:TECPAR
instname_str Instituto de Tecnologia do Paraná (Tecpar)
instacron_str TECPAR
institution TECPAR
reponame_str Brazilian Archives of Biology and Technology
collection Brazilian Archives of Biology and Technology
repository.name.fl_str_mv Brazilian Archives of Biology and Technology - Instituto de Tecnologia do Paraná (Tecpar)
repository.mail.fl_str_mv babt@tecpar.br||babt@tecpar.br
_version_ 1750318268291219456